Cefuroxime is an enteral second-generation cephalosporin antibiotic.
As with the other cephalosporins, it is susceptible to beta-lactamase, although as a second-generation variety, it is less so. Hence, it may have greater activity against Haemophilus influenzae, Neisseria gonorrhoeae, and Lyme disease. Unlike most other second-generation cephalosporins, cefuroxime can cross the blood-brain barrier.
Specification:
|
Items |
Specification |
Results |
|
Appearance |
A White or almost white powder |
Complies |
|
Identification |
IR spectrum exhibit maxima at the same wave numbers as the reference standard spectrum. |
Complies |
|
Crystallinity |
Do not show birefringence or exhibit extinction position. |
Complies |
|
Loss on drying |
≤1.3% |
0.69% |
|
Diasetereoisomer ratio |
0.48 – 0.55 |
0.52 |
|
Heavy metals |
≤ 20 ppm |
< 20ppm |
|
Assay |
745 – 875 ug/mg |
818 ug/mg |
|
Conclusiion |
This product complied with the standard of USP 36 |
|
Packaging details:
|
Packaging details: |
25kg/drum with double plastic bags inside; packed in a cardboard drum or fiber HDPE drum. |
|
Storage: |
Stored in a clean, cool, dry area; keep away from moisture and strong, direct light/heat |
|
Shelf Life: |
5 years if sealed and store away from direct sun light. |